Guselkumab Clinical Trials
16 recruitingDrug
Phase 36Phase 45Phase 23Not Applicable2
Showing 1–16 of 16 trials
Recruiting
Phase 4
A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
Arthritis, Psoriatic
Johnson & Johnson Private Limited100 enrolled10 locationsNCT07141004
Recruiting
Phase 3
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Janssen Research & Development, LLC120 enrolled85 locationsNCT05923073
Recruiting
Phase 3
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Colitis UlcerativeArthritis, PsoriaticCrohns Disease+1 more
Janssen Research & Development, LLC196 enrolled42 locationsNCT06663332
Recruiting
Phase 3
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Janssen Research & Development, LLC530 enrolled11 locationsNCT07499232
Recruiting
Phase 4
GUselkumAb inteRvention and DIet evaluAtioN for Pouchitis
Pouchitis
Universitaire Ziekenhuizen KU Leuven20 enrolled1 locationNCT06916390
Recruiting
Phase 3
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Crohn's Disease
Janssen-Cilag Ltd.112 enrolled84 locationsNCT06408935
Recruiting
Not Applicable
A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis
Psoriasis
Second Affiliated Hospital, School of Medicine, Zhejiang University400 enrolled1 locationNCT07532486
Recruiting
Phase 4
Multi-Center PAMPA Study
Psoriasis
NYU Langone Health176 enrolled5 locationsNCT05004727
Recruiting
Phase 2
Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)
Pyoderma GangrenosumWound HealSkin Diseases+2 more
Oregon Health and Science University17 enrolled2 locationsNCT06563323
Recruiting
Phase 2
Efficacy of Guselkumab in Treating Hailey Hailey Disease
Hailey Hailey Disease
Yale University10 enrolled1 locationNCT06651489
Recruiting
Phase 2Phase 3
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
Skin InflammationAllergic Contact Dermatitis
Wei-Che Ko45 enrolled1 locationNCT05535738
Recruiting
Phase 3
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
Psoriatic Arthritis
University of Pennsylvania63 enrolled14 locationsNCT05669833
Recruiting
Phase 4
Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.
Psoriasis Arthritis
Fondazione Policlinico Universitario Campus Bio-Medico26 enrolled1 locationNCT06974474
Recruiting
Not Applicable
Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
Psoriatic Arthritis
University of California, San Diego20 enrolled1 locationNCT06586281
Recruiting
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
PregnancyCrohn DiseasePsoriasis+1 more
University of California, San Diego200 enrolled1 locationNCT02103361
Recruiting
Phase 4
Immune Spatial Features of Guselkumab Cutaneous Response
Psoriasis of Scalp
University of California, San Francisco10 enrolled1 locationNCT05858632